Quantcast

Latest Ejection fraction Stories

2014-06-04 14:50:47

Duke University Medical Center Implantable cardioverter defibrillators (ICDs) are associated with improved survival among heart failure patients whose left ventricles only pump 30 to 35 percent of blood out of the heart with each contraction, according to a study from the Duke Clinical Research Institute. The findings, published in the June 4 issue of the Journal of the American Medical Association, support existing recommendations to implant ICDs in patients with a left ventricular...

2014-01-06 08:26:19

- Statistically significant improvement in key parameters of heart function, including left ventricular ejection fraction and cardiac output SAN DIEGO, Jan. 6, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today announced that, in a placebo-controlled, nonclinical model of chronic heart failure, MST-188 demonstrated a statistically significant improvement in numerous parameters of heart function, including left ventricular ejection fraction and end-systolic volume,...

2013-02-27 10:59:47

Among patients with heart failure with preserved ejection fraction, long-term treatment with the medication spironolactone improved left ventricular diastolic function but did not affect maximal exercise capacity, patient symptoms, or quality of life, according to a study appearing in the February 27 issue of JAMA. "Heart failure (HF) with preserved ejection fraction [EF; the percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat is 50 percent or greater]...

2012-03-08 14:46:57

Male gender deemed an independent risk factor for mortality over 3-year study period in 40,000+ patients Women with chronic heart failure survive longer than their male counterparts, according to a large analysis of studies comprising data on more than 40,000 subjects. The analysis represents the largest assessment of gender and mortality risk in heart failure - and provides evidence which many randomised trials have failed to do because they have been dominated by male patients. Heart...

2010-09-25 11:00:00

PHILADELPHIA, Sept. 25 /PRNewswire/ -- Today, researchers presented new data showing molecular imaging agent 123I-mIBG can help cardiologists define risk in heart failure patients. As an extension of the ADMIRE-HF trial, the ADMIRE-HFX study assessed 123I-mIBG as a risk stratifier for arrhythmic events and cardiac death in subjects with heart failure. The original ADMIRE-HF trial studied 961 heart failure subjects with left ventricular ejection fraction who underwent planar and SPECT...

2010-05-17 08:00:00

PRINCETON, N.J., May 17 /PRNewswire-FirstCall/ -- The ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) trial, the results of which were published in the May 18th, 2010 issue of the Journal of the American College of Cardiology, is a prospective study evaluating cardiac sympathetic nerve imaging using Iobenguane I 123 Injection (AdreView(TM)) for identifying symptomatic heart failure patients most likely to experience cardiac events. According to the study, the...

2010-02-16 14:36:53

New research from the University of Alabama at Birmingham (UAB) suggests that the ability of right side of the heart to pump blood may be an indication of the risk of death to heart-failure patients whose condition is caused by low function by the left side of their heart. The ability of the two chambers of the heart, the left and right ventricles, to pump blood is described as ejection fraction. Healthy individuals typically have ejection fractions between 50 and 65 percent in both...

2008-11-14 09:00:34

SAN DIEGO, Nov. 14 /PRNewswire-FirstCall/ -- CardioDynamics , the innovator and leader of Impedance Cardiography (ICG) technology and manufacturer of BioZ noninvasive cardiac monitoring systems, announced today two studies which correlate BioZ(R) with Ejection Fraction (EF) from echocardiography (echo). Researchers from Stanford Medical Center, Stanford, California, reported results of a pacemaker optimization study at the Twelfth Annual Heart Failure Society of America (HFSA) Scientific...

2008-10-15 09:00:48

Daxor Corporation (AMEX: DXR), a medical instrumentation and biotechnology company, announced the publication of a comparison study of the blood volume and anemia characteristics in heart failure patients in the October 2008 issue of The American Journal of Cardiology. In the study, heart failure patients were categorized on the basis of whether they had a normal ejection fraction versus a low ejection fraction. An ejection fraction is a measurement of how much blood is pumped out of the...

2008-09-03 09:00:46

New analyses presented today during the annual congress of the European Society of Cardiology (ESC) on the effects of cardiac resynchronisation therapy (CRT) in patients with mild heart failure from the REVERSE (Resynchronisation Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial show improvement in several areas, including left ventricular ejection fraction (LVEF), a standard measure of the heart's pumping effectiveness and a key indicator of heart health. Patients with CRT...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related